Rolf Thieringer - Concepedia

Author

Rolf Thieringer

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

R Thieringer, R. THIERINGER, R. Thieringer, Rolf Thieringer

Publications

4.6K

Citations

H-Index

105

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Université Laval Rockefeller University Icahn School of Medicine at Mount Sinai Rosetta Stone (United States)

About

Rolf Thieringer is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	31	3.3K
2	Natural Sciences	8	8	423
3	Health Sciences	7	7	320
4	Engineering	4	4	160
5	Public Health	3	3	1.3K

Rolf Thieringer

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
An integrative genomics approach to infer causal associations between gene expression and disease Eric E. Schadt, John R. Lamb, Xia Yang, Nature Genetics Genome-wide Association StudyCausal AssociationsEpidemiologyGene-environment InteractionFunctional Genomics	2005	1K
11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice Anne Hermanowski‐Vosatka, James M. Balkovec, Kang Cheng, The Journal of Experimental Medicine	2005	362
An integrative genomics approach to the reconstruction of gene networks in segregating populations Jun Zhu, Pek Yee Lum, John R. Lamb, Cytogenetic and Genome Research GeneticsSuch ReconstructionsInteraction NetworkSegregating Mouse PopulationNetwork Analysis	2004	226
Peroxisome Proliferator-activated Receptor-γ Ligands Inhibit Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity Joel P. Berger, Michael Tanen, Alex Elbrecht, Journal of Biological Chemistry	2001	206
Activation of Peroxisome Proliferator-Activated Receptor γ Does Not Inhibit IL-6 or TNF-α Responses of Macrophages to Lipopolysaccharide In Vitro or In Vivo Rolf Thieringer, Judy Fenyk‐Melody, Cheryl B. Le Grand, The Journal of Immunology Immune RegulationImmunologyCell DeathPpargamma AgonistsImmunotherapy	2000	194
CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Russell L. Delude, R Savedra, Hongwei Zhao, Proceedings of the National Academy of Sciences Microbial PathogensHamster MacrophagesInnate Immune SystemImmunologyImmunologic Mechanism	1995	182
11β-Hydroxysteroid Dehydrogenase Type 1 Is Induced in Human Monocytes upon Differentiation to Macrophages Rolf Thieringer, Cheryl B. Le Grand, Linda Carbin, The Journal of Immunology Chronic Inflammatory DiseasesImmunologyGlucocorticoidInflammationCell Signaling	2001	174
Targeted Deletion of the Lipopolysaccharide (LPS)-binding Protein Gene Leads to Profound Suppression of LPS Responses Ex Vivo, whereas In Vivo Responses Remain Intact Mark M. Wurfel, Brian G. Monks, Robin R. Ingalls, The Journal of Experimental Medicine	1997	174
The Role of CD14 in Signaling Mediated by Outer Membrane Lipoproteins of <i>Borrelia burgdorferi</i> R. Mark Wooten, Tom Morrison, John H. Weis, The Journal of Immunology	1998	145
Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers I‐Ming Wang, Bin Zhang, Xia Yang, Molecular Systems Biology	2012	136

Page 1